Fund Description
The investment seeks investment results that correspond (before fees and expenses) to the price and yield performance of the Dow Jones Emerging Markets Health Care Titans 30 IndexSM. Under normal circumstances, the fund will invest at least 80% of its net assets in securities of Emerging Markets Health Care companies that are included in the fund's Health Care underlying index and generally expects to be substantially invested at such times, with at least 95% of its net assets invested in those securities. The fund is non-diversified.
Fund Snapshot Updated 05.20.2013
| Previous Close | $24.74 | Expense Ratio | 0.85% |
| YTD Return | 11.7% | Avg. 30-Day Volume | 3,250 |
| 1-Year Return | 38.7% | Market Cap | Loading... |
| Bid | $24.86 | Shares Outstanding | 250,000 |
| Ask | $25.07 | Dividends | $0.04 |
| Top 10 Holdings | |
|---|---|
| Aspen Pharmacare (E:APN) | 11.05% |
| Sun Pharmaceutical (E:SUNPHARMA.EQ) | 10.50% |
| Life Healthcare Gr (E:LHC) | 6.55% |
| Mindray Medical Intl Ltd (MR) | 6.22% |
| Kalbe Farma (E:KLBF) | 5.91% |
| Dr Reddys Labs Ltd (RDY) | 5.13% |
| Netcare Limited (E:NTC) | 4.82% |
| Cipla (E:CIPLA.EQ) | 4.45% |
| Mediclinic Intl (E:MDC) | 4.13% |
| Sinopharm Group Co (E:1099) | 4.11% |
| % of Total Holdings | 62.90% |
